en

PRODUCT DETAIL

Tyenne 162 mg injekčný roztok v naplnenej injekčnej striekačke

Code 4532E
MA number EU/1/23/1754/008
Product Form: sol iru 4x0,9 ml/162 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AC Interleukin inhibitors
L04AC07 Tocilizumab
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 15.09.2023
Validity: 15.09.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 06.10.2023
eu-flag.png sk-flag.png